Cover Image

Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia

We employed enzyme immunoassay (EIA) and Western blotting techniques to measure the level of antibodies to Toxoplasma gondii proteins in serum samples from 38 individuals undergoing their first episode of schizophrenia and from a group of matched control subjects. We found that the individuals with...

Full description

Saved in:
Bibliographic Details
Main Authors: Yolken, Robert H. (Author) , Bachmann, Silke (Author) , Rouslanova, Inna (Author) , Lillehoj, Erik (Author) , Ford, Glen (Author) , Torrey, Edwin F. (Author) , Schröder, Johannes (Author)
Format: Article (Journal)
Language:English
Published: 01 March 2001
In: Clinical infectious diseases
Year: 2001, Volume: 32, Issue: 5, Pages: 842-844
ISSN:1537-6591
DOI:10.1086/319221
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1086/319221
Get full text
Author Notes:Robert H. Yolken, Silke Bachmann, Inna Rouslanova, Erik Lillehoj, Glen Ford, E. Fuller Torrey, and Johannes Schroeder

MARC

LEADER 00000caa a2200000 c 4500
001 1742180752
003 DE-627
005 20220819044002.0
007 cr uuu---uuuuu
008 201207s2001 xx |||||o 00| ||eng c
024 7 |a 10.1086/319221  |2 doi 
035 |a (DE-627)1742180752 
035 |a (DE-599)KXP1742180752 
035 |a (OCoLC)1341383235 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Yolken, Robert H.  |e VerfasserIn  |0 (DE-588)1222917416  |0 (DE-627)1742181856  |4 aut 
245 1 0 |a Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia  |c Robert H. Yolken, Silke Bachmann, Inna Rouslanova, Erik Lillehoj, Glen Ford, E. Fuller Torrey, and Johannes Schroeder 
264 1 |c 01 March 2001 
300 |a 3 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 07.12.2020 
520 |a We employed enzyme immunoassay (EIA) and Western blotting techniques to measure the level of antibodies to Toxoplasma gondii proteins in serum samples from 38 individuals undergoing their first episode of schizophrenia and from a group of matched control subjects. We found that the individuals with first-episode schizophrenia had significantly increased levels of IgG, IgM, and IgA class antibodies to Toxoplasma proteins, as compared with the control subjects. 
700 1 |a Bachmann, Silke  |e VerfasserIn  |0 (DE-588)173977952  |0 (DE-627)675066719  |0 (DE-576)134814894  |4 aut 
700 1 |a Rouslanova, Inna  |e VerfasserIn  |4 aut 
700 1 |a Lillehoj, Erik  |e VerfasserIn  |4 aut 
700 1 |a Ford, Glen  |e VerfasserIn  |4 aut 
700 1 |a Torrey, Edwin F.  |d 1937-  |e VerfasserIn  |0 (DE-588)113747217  |0 (DE-627)392381354  |0 (DE-576)289773326  |4 aut 
700 1 |a Schröder, Johannes  |d 1957-  |e VerfasserIn  |0 (DE-588)138708517  |0 (DE-627)605263469  |0 (DE-576)308769848  |4 aut 
773 0 8 |i Enthalten in  |t Clinical infectious diseases  |d Oxford : Oxford Journals, 1992  |g 32(2001), 5, Seite 842-844  |h Online-Ressource  |w (DE-627)320418308  |w (DE-600)2002229-3  |w (DE-576)090881834  |x 1537-6591  |7 nnas  |a Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia 
773 1 8 |g volume:32  |g year:2001  |g number:5  |g pages:842-844  |g extent:3  |a Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia 
856 4 0 |u https://doi.org/10.1086/319221  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201207 
993 |a Article 
994 |a 2001 
998 |g 138708517  |a Schröder, Johannes  |m 138708517:Schröder, Johannes  |d 910000  |d 910600  |e 910000PS138708517  |e 910600PS138708517  |k 0/910000/  |k 1/910000/910600/  |p 7  |y j 
998 |g 173977952  |a Bachmann, Silke  |m 173977952:Bachmann, Silke  |d 50000  |e 50000PB173977952  |k 0/50000/  |p 2 
999 |a KXP-PPN1742180752  |e 381825687X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title_sort":"Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia","title":"Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia"}],"relHost":[{"note":["Gesehen am 31.07.2023"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Antibodies to Toxoplasma gondii in individuals with first-episode schizophreniaClinical infectious diseases","id":{"eki":["320418308"],"zdb":["2002229-3"],"issn":["1537-6591"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320418308","origin":[{"publisherPlace":"Oxford ; Chicago, Ill.","dateIssuedDisp":"1992-","publisher":"Oxford Journals ; Univ. of Chicago Press, Journals Division","dateIssuedKey":"1992"}],"pubHistory":["14.1992 -"],"language":["eng"],"part":{"issue":"5","extent":"3","pages":"842-844","volume":"32","year":"2001","text":"32(2001), 5, Seite 842-844"},"title":[{"title_sort":"Clinical infectious diseases","title":"Clinical infectious diseases","subtitle":"electronic edition"}]}],"note":["Gesehen am 07.12.2020"],"id":{"doi":["10.1086/319221"],"eki":["1742180752"]},"physDesc":[{"extent":"3 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1742180752","origin":[{"dateIssuedDisp":"01 March 2001","dateIssuedKey":"2001"}],"person":[{"family":"Yolken","given":"Robert H.","role":"aut","display":"Yolken, Robert H."},{"given":"Silke","role":"aut","display":"Bachmann, Silke","family":"Bachmann"},{"display":"Rouslanova, Inna","role":"aut","given":"Inna","family":"Rouslanova"},{"family":"Lillehoj","display":"Lillehoj, Erik","given":"Erik","role":"aut"},{"given":"Glen","role":"aut","display":"Ford, Glen","family":"Ford"},{"display":"Torrey, Edwin F.","given":"Edwin F.","role":"aut","family":"Torrey"},{"display":"Schröder, Johannes","given":"Johannes","role":"aut","family":"Schröder"}],"name":{"displayForm":["Robert H. Yolken, Silke Bachmann, Inna Rouslanova, Erik Lillehoj, Glen Ford, E. Fuller Torrey, and Johannes Schroeder"]}} 
SRT |a YOLKENROBEANTIBODIES0120 

Similar Items